Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Mycophenolate mofetil

2

I.b Pneumonitis (ILD)

1
Last update : 06/09/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist

Publications

Reversible diffuse lung disease after mycophenolate mofetil withdrawal.
Pulmonology 2018;24;361-362 2018
Unusual Case of Acute Lung Injury in a Renal Allograft Recipient.
Indian journal of nephrology 2017;27;215-217 2017
Reversible interstitial lung disease following treatment of atopic dermatitis with mycophenolate mofetil.
Clinical and experimental dermatology 2016 Aug;41;702-3 2016 Aug
Severe pneumonia in mycophenolate mofetil combined with low-dose corticosteroids-treated patients with immunoglobulin A nephropathy.
The Kaohsiung journal of medical sciences 2015 Jan;31;42-6 2015 Jan
Pneumonitis associated with the use of mycophenolate mofetil.
Transplantation 2003 May 27;75;1762 2003 May 27

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies